Pharmaceutical Industry News

* FDA panel says suvorexant safe, effective at lower doses * Merck drug is first in new class of sedatives WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug moved a step closer to

all 2 news articles >>

Wall Street falters in volatile session on Fed worries - 2 Hours ago

NEW YORK: Stocks fell on Wednesday with the S&P 500 posting its biggest decline in three weeks, after minutes from the latest Federal Reserve meeting showed some officials were open to tapering large-scale

all 4 news articles >>

Senate panel approves bill to tighten compounding pharmacies’ oversight - 65 Minutes ago

Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past falls deadly meningitis outbreak,

Repros Therapeutics Inc Announces That FDA Recommends Running Phase 2b Trial Of - 82 Minutes ago

Repros Therapeutics Inc announced it has met with the FDA regarding the clinical development of Proellex-V, the vaginally administered product, in the treatment of uterine fibroids. The FDA recommended

FDA Recommends Running Phase 2b Trial of Proellex(R)-V in the Treatment of Severe - 3 Hours ago

Press Release: Repros Therapeutics Inc. – 14 minutes ago Email 0 Recommend 0 Tweet 0 Share 0 RELATED QUOTES Symbol Price Change -0.32 THE WOODLANDS, Texas, May 22, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics

FDA Recommends Running Phase 2b Trial of Proellex(R)-V in the Treatment of Severe - 3 Hours ago

(GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(R) (RPRX) today announced it has met with the FDA regarding the clinical development of Proellex-V, the vaginally administered product, in the treatment of

American Express takes you places

Sponsored

- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents. Try AdBlade and begin reaching your targ. Learn More

Assns of Ayurveda docs send proposals for new health policy to state govt - 47 Minutes ago

Stating that Ayurveda, an alternate system of medicine in Kerala is going through a rough time, the associations of manufacturers and practitioners of this traditional system have submitted a set of proposals

Drug-eluting Balloons for de novo coronary artery disease: A meta-analysis of angiographic - 50 Minutes ago

Abstract Objectives : To evaluate the effectiveness of drug-eluting balloons (DEBs) in the treatment of de novo coronary artery disease by performing a meta-analysis of randomized controlled trials

Olay's Fresh Effects skin care line caters to younger generation - 55 Minutes ago

Earlier this year Olay's new Fresh Effects skin care line hit retail shelves — but in an unprecedented way for the beauty brand. "As we were doing a lot of analysis and understanding and looking at trends,

FDA Panel Backs Mercks Low-dose Insomnia Drug - 89 Minutes ago

FDA WEBVIEW FREE TRIAL REQUEST Please complete the following fields in order to request a free trial to Dickinson's FDA Webview: All Fields are required.

Public Meeting On Standardizing REMS - 89 Minutes ago

FDA WEBVIEW FREE TRIAL REQUEST Please complete the following fields in order to request a free trial to Dickinson's FDA Webview: All Fields are required.

FDA Accepts Upsher-Smith NDA for Epilepsy - 89 Minutes ago

FDA WEBVIEW FREE TRIAL REQUEST Please complete the following fields in order to request a free trial to Dickinson's FDA Webview: All Fields are required.

Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Benign Mammary - 112 Minutes ago

Background Nonmalignant mammary tumors (NMT) are common in intact female dogs. Little is known about the clinical significance of these tumors, and the effect of ovariohysterectomy (OHE) on their development.

Merck Statement on FDA Advisory Committee Meeting for Suvorexant - 2 Hours ago

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee

Ahead of Global Layoffs, Ranbaxy Touts Quality/Compliance Changes - 3 Hours ago

FDA WEBVIEW FREE TRIAL REQUEST Please complete the following fields in order to request a free trial to Dickinson's FDA Webview: All Fields are required.

Pfizer to spin off rest of Zoetis - 3 Hours ago

The pharmaceutical giant announced that it will spin off the rest of its animal-health unit Zoetis (ZTS) on June 19, just shy of 5 months after it sold off 20% of it in an IPO. Pfizer (PFE) will use an

uniQure and consortium to receive EUR 2.5 million Eurostars grant to develop RNAi - 3 Hours ago

The security settings of your browser are blocking the execution of scripts. To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript. If

FDA Recommends Running Phase 2b Trial of Proellex(R)-V in the Treatment of Severe - 3 Hours ago

Repros Therapeutics Inc.(Nasdaq:RPRX) today announced it has met with the FDA regarding the clinical development of Proellex-V, the vaginally administered product, in the treatment of uterine fibroids.

AMAG slides on Rienso recall in Switzerland - 2 Hours ago

AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) fell $2.68 (11%) to $22.40 on Wednesday after disclosing in an SEC filing that partner Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is recalling a batch of anemia

all 4 news articles >>